Latin America And Central America Isotretinoin Drugs Market Research Report Forecast to 2030

Latin America and Central America Isotretinoin Drugs Market Research Report Forecast to 2030
The LATAM and CAM isotretinoin drugs market is growing because of factors such as the rising prevalence of nodulocystic acne and the increasing incidences of chronic diseases among young adults, such as obesity and diabetes. Furthermore, growing awareness associated with the isotretinoin drug and sound knowledge of maintaining nodulocystic acne further create lucrative growth opportunities. However, side effects associated with the isotretinoin drug and an increasing preference for alternatives are impeding the market's growth.

The drug isotretinoin is used to treat severe nodulocystic acne and other acne that does not respond to other treatments. It works by inhibiting the function of the sebaceous gland and keratinization. Isotretinoin drugs are utilized for the treatment of severe inflammatory acne along with other skin disorders.

Market Segmentation
Based on form, the LATAM and CAM isotretinoin drugs market has been segmented into capsule and gel. The capsule segment dominated the market in 2021 and gel is projected to be the fastest-growing during the forecast period, 2022–2030.

Based on end user, the LATAM and CAM isotretinoin drugs market has been segmented into public sector and private sector.

Regional Analysis
The Latin America and Central America region is driven by several factors, including high consumption of ultra-processed food, alcohol, and smoke, which are the main causes of nodulocystic acne. Moreover, increasing incidences of diabetes, obesity, Polycystic Ovary Syndrome, Diabetes (PCOS), and depression diseases resist insulin, which causes nodular and cystic acne, boosting the market growth. The Latin America region dominated the market in 2021, and Central America is projected to be the fastest-growing during the forecast period, 2022–2030.

Major Players
Cipher Pharmaceuticals (US), Journey Medical Corporation (US), by Viatris Inc. (US), Teva Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories (India), Procaps S.A.(Colombia), Advaita Pharmaceuticals (Mexico), EMS (Brazil), Cipher Pharmaceuticals (Canada), Akorn Operating Company LLC (US), and Stiefel Laboratories (US).

Companies Mentioned
Cipher Pharmaceuticals (US)
Journey Medical Corporation (US)
by Viatris Inc. (US)
Teva Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories (India)
Procaps S.A.(Colombia)
Advaita Pharmaceuticals (Mexico)
EMS (Brazil)
Cipher Pharmaceuticals (Canada)
Akorn Operating Company LLC (US)
and Stiefel Laboratories (US).

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.